NINGBO YINGMED MEDICAL INSTRUMENTS CO.,LTD
Ningbo Yingmed Medical Instruments Co., Ltd is one of the professional supplier for the Medical Instuments products in China. Our Team has more than 15 years experiences in Medical field.
We export our products to customers in Europen, South Africa, South east of Asia, South America, Middle East. We are facroty , located in Jiangsu province, which is near Shanghai port, we produce Oxygen mask, Nebulizer mask, ET tubes, Latex Foley catheter, Tracheostomy tube, Syringe, and etc.
In order to fufill and increasing needs of our trusted and loyal customers, apart from our factory, we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing, syringes, diagnostics & lab products.
We care the success of our customers, we know that the important of quality, so we set up a strong QC team stay in differences production lines to ensure & control quality.
Our Company is approved by CE&ISO certificates for most of products.
In future, Yingmed Medical will keep high efficient and professional for every cutomer, and associate company development with human health. We will do our best to put love and respect into our every product, and pass smile to everyone at the world.
NINGBO YINGMED MEDICAL INSTRUMENTS CO.,LTD
Ningbo Yingmed Medical Instruments Co., Ltd is one of the professional supplier for the Medical Instuments products in China. Our Team has more than 15 years experiences in Medical field.
We export our products to customers in Europen, South Africa, South east of Asia, South America, Middle East. We are facroty , located in Jiangsu province, which is near Shanghai port, we produce Oxygen mask, Nebulizer mask, ET tubes, Latex Foley catheter, Tracheostomy tube, Syringe, and etc.
In order to fufill and increasing needs of our trusted and loyal customers, apart from our factory, we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing, syringes, diagnostics & lab products.
We care the success of our customers, we know that the important of quality, so we set up a strong QC team stay in differences production lines to ensure & control quality.
Our Company is approved by CE&ISO certificates for most of products.
In future, Yingmed Medical will keep high efficient and professional for every cutomer, and associate company development with human health. We will do our best to put love and respect into our every product, and pass smile to everyone at the world.
Chengdu Rich Science Industry Co., Ltd.
Headquartered in Chengdu hi-tech district, Chengdu Rich Science Industry Co., Ltd. is a hi-tech company with advanced research and development capability and first-class management.
We are devoting ourselves to research, production and marketing of hi-tech medical, biological medical devices. Our main products are Vacuum Blood Collection System, body juice specimen collection system, bacteria culture/verification system, bio-informational products, instruments and medical reagents which are used extensively in the fields of pharmacology, test, teaching and science research.We have obtained ISO9001:2000, ISO13485:2003 certificate and CE approval in 2005.
Based on our ontinuous principle of "C.D.RICH technology for society", we would like to make good cooperation with you.
Chengdu Rich Science Industry Co., Ltd.
Headquartered in Chengdu hi-tech district, Chengdu Rich Science Industry Co., Ltd. is a hi-tech company with advanced research and development capability and first-class management.
We are devoting ourselves to research, production and marketing of hi-tech medical, biological medical devices. Our main products are Vacuum Blood Collection System, body juice specimen collection system, bacteria culture/verification system, bio-informational products, instruments and medical reagents which are used extensively in the fields of pharmacology, test, teaching and science research.We have obtained ISO9001:2000, ISO13485:2003 certificate and CE approval in 2005.
Based on our ontinuous principle of "C.D.RICH technology for society", we would like to make good cooperation with you.
Wuxi Gukang Medical Equipment Co., Ltd.
Wuxi GUKANG Medical Equipment Co.,Ltd is set up in 2000,located in Wuxi Jiangyin where about 2 hours' drive from Shanghai.We have witnessed the vigorous development of the medical device industry,and have also been continuously optimizing its own infrastructure equipment and personnel as the industry becomes more standardize.Usually we have customized services for each customer in order to provide the heroes on the frontlines of healthcare with safer and more convenient products.Stable quality and Patient service have helped us accumulate a lot of customer resources,from which we have also gained rich experience so that we can provide customers with professional and diversified solutions in the future.
Wuxi Gukang Medical Equipment Co., Ltd.
Wuxi GUKANG Medical Equipment Co.,Ltd is set up in 2000,located in Wuxi Jiangyin where about 2 hours' drive from Shanghai.We have witnessed the vigorous development of the medical device industry,and have also been continuously optimizing its own infrastructure equipment and personnel as the industry becomes more standardize.Usually we have customized services for each customer in order to provide the heroes on the frontlines of healthcare with safer and more convenient products.Stable quality and Patient service have helped us accumulate a lot of customer resources,from which we have also gained rich experience so that we can provide customers with professional and diversified solutions in the future.
ICU Medical is a leading manufacturer of infusion systems, IV sets, and other medical devices used in hospitals and clinics. They are known for their innovative solutions and commitment to patient safety.
ICU Medical, Inc.
ICU Medical is a leading manufacturer of infusion systems, IV sets, and other medical devices used in hospitals and clinics. They are known for their innovative solutions and commitment to patient safety.
Huaqiang Medical Technology Co., Ltd.
Huaqiang is a Chinese company that manufactures a variety of medical devices, including IV sets, syringes, and other disposables. They are known for their quality and reliability.
Huaqiang Medical Technology Co., Ltd.
Huaqiang is a Chinese company that manufactures a variety of medical devices, including IV sets, syringes, and other disposables. They are known for their quality and reliability.
Medfusion is a brand under Smiths Medical that specializes in infusion pump systems and IV sets for hospitals and other medical facilities.
Smiths Medical
Medfusion is a brand under Smiths Medical that specializes in infusion pump systems and IV sets for hospitals and other medical facilities.
Zhejiang Jinghong Medical Apparatus Co., Ltd.
Jinghong is a Chinese company specializing in the production of disposable medical devices such as IV sets, syringes, and catheters. They are known for their high-quality products and competitive pricing.
Zhejiang Jinghong Medical Apparatus Co., Ltd.
Jinghong is a Chinese company specializing in the production of disposable medical devices such as IV sets, syringes, and catheters. They are known for their high-quality products and competitive pricing.
BD (Becton, Dickinson and Company)
Alaris by BD is a leading provider of infusion systems, offering advanced technology for precise medication delivery in healthcare settings.
BD (Becton, Dickinson and Company)
Alaris by BD is a leading provider of infusion systems, offering advanced technology for precise medication delivery in healthcare settings.
Becton, Dickinson and Company
CareFusion, now part of BD, provides respiratory care products, including ventilators and airway management devices, to improve patient safety and clinical outcomes.
Becton, Dickinson and Company
CareFusion, now part of BD, provides respiratory care products, including ventilators and airway management devices, to improve patient safety and clinical outcomes.
Smiths Medical specializes in medical devices and equipment, including ventilators and respiratory care products, to support patients and healthcare providers globally.
Smiths Group plc
Smiths Medical specializes in medical devices and equipment, including ventilators and respiratory care products, to support patients and healthcare providers globally.
B. Braun offers a comprehensive range of surgical instruments, including bone-cutting tools, known for their precision and durability.
B. Braun Melsungen AG
B. Braun offers a comprehensive range of surgical instruments, including bone-cutting tools, known for their precision and durability.
Cook Medical Trading (China) Co., Ltd.
Cook Medical is a medical device company from Indiana, USA. It was founded in 1963 by Mr. Bill Cook and his wife. Currently, Cook Medical's business covers 135 countries and regions around the world, with products covering more than 60 professional disciplines, and its production bases are mainly located in the United States, Europe and Australia. It has 6 major logistics distribution centers, multiple local warehousing and distribution centers, as well as more than 10,000 employees worldwide. Since its establishment, Cook Medical has adhered to the operating model of a family business. Unlike listed companies, unique individuality gives full space to consider issues from a long-term perspective, and there is no need to compromise on short-term business interests, truly adhering to the concept, original intention, and realizing the commitment to patients. The company's products have been in the Chinese market for more than 30 years. In 2008, Cook (China) Medical Trading Co., Ltd. was established in Shanghai. Currently, Cook China has two offices in Shanghai and Beijing, of which the Shanghai office is the operation headquarters of Cook China. In the future, Cook Medical will move forward steadily with full enthusiasm and confidence, professional knowledge and rich experience, and provide better products to serve patients and physicians.
Cook Medical Trading (China) Co., Ltd.
Cook Medical is a medical device company from Indiana, USA. It was founded in 1963 by Mr. Bill Cook and his wife. Currently, Cook Medical's business covers 135 countries and regions around the world, with products covering more than 60 professional disciplines, and its production bases are mainly located in the United States, Europe and Australia. It has 6 major logistics distribution centers, multiple local warehousing and distribution centers, as well as more than 10,000 employees worldwide. Since its establishment, Cook Medical has adhered to the operating model of a family business. Unlike listed companies, unique individuality gives full space to consider issues from a long-term perspective, and there is no need to compromise on short-term business interests, truly adhering to the concept, original intention, and realizing the commitment to patients. The company's products have been in the Chinese market for more than 30 years. In 2008, Cook (China) Medical Trading Co., Ltd. was established in Shanghai. Currently, Cook China has two offices in Shanghai and Beijing, of which the Shanghai office is the operation headquarters of Cook China. In the future, Cook Medical will move forward steadily with full enthusiasm and confidence, professional knowledge and rich experience, and provide better products to serve patients and physicians.
Nipro Trading (Shanghai) Co., Ltd.
NIPRO is at the forefront of global medical care and constantly challenges the unknown areas of life sciences. With persistent commitment to the research and development and innovation of cutting-edge medical products, NIPRO has been able to provide excellent technologies and products for various fields such as medical equipment and medicines. A variety of patented technologies used in artificial kidneys and various disposable medical devices give this medical product unprecedented functions and characteristics. NIPRO has also carried out close cooperation with many multinational pharmaceutical companies (Pfizer, Novartis, Astra Zeneca, Takeda, Astellas, etc.), and through the design and optimization of the original dosage form, the bioavailability and safety of the drug are improved. The cooperation areas cover professional fields such as tumors, respiratory, kidney disease, rare diseases, anti-infection, and mental illness. The persistent pursuit of product quality has made NIPRO highly evaluated in the global clinical medical field. Especially in the fields of nephrological artificial organs and regenerative medicine, NIPRO has become a world-leading brand. Nipulo Trading (Shanghai) Co., Ltd. was officially established in Shanghai in 2003. It is mainly engaged in the sales of Nipro related products in the Chinese market. NIPRO has gained the trust and support of more and more clinical experts with its high-quality products and continuous improvement services. China in the early 1990s lacked foreign currency, and it was very difficult to buy dialysis machines and dialyzers from Japan at the same time. Nipulo Shanghai Contact Office (the predecessor of Nipulo Trading (Shanghai) Co., Ltd.) has helped China clinically carry out dialysis treatment since 1993, and has given dialysis machines to 10 Chinese hospitals for free, so many patients were treated, which also made the hospital. Saved a lot of money.
Nipro Trading (Shanghai) Co., Ltd.
NIPRO is at the forefront of global medical care and constantly challenges the unknown areas of life sciences. With persistent commitment to the research and development and innovation of cutting-edge medical products, NIPRO has been able to provide excellent technologies and products for various fields such as medical equipment and medicines. A variety of patented technologies used in artificial kidneys and various disposable medical devices give this medical product unprecedented functions and characteristics. NIPRO has also carried out close cooperation with many multinational pharmaceutical companies (Pfizer, Novartis, Astra Zeneca, Takeda, Astellas, etc.), and through the design and optimization of the original dosage form, the bioavailability and safety of the drug are improved. The cooperation areas cover professional fields such as tumors, respiratory, kidney disease, rare diseases, anti-infection, and mental illness. The persistent pursuit of product quality has made NIPRO highly evaluated in the global clinical medical field. Especially in the fields of nephrological artificial organs and regenerative medicine, NIPRO has become a world-leading brand. Nipulo Trading (Shanghai) Co., Ltd. was officially established in Shanghai in 2003. It is mainly engaged in the sales of Nipro related products in the Chinese market. NIPRO has gained the trust and support of more and more clinical experts with its high-quality products and continuous improvement services. China in the early 1990s lacked foreign currency, and it was very difficult to buy dialysis machines and dialyzers from Japan at the same time. Nipulo Shanghai Contact Office (the predecessor of Nipulo Trading (Shanghai) Co., Ltd.) has helped China clinically carry out dialysis treatment since 1993, and has given dialysis machines to 10 Chinese hospitals for free, so many patients were treated, which also made the hospital. Saved a lot of money.
Smith Medical Devices (Beijing) Co., Ltd.
ICU Medical was founded in 1984 and is headquartered in San Clemente, California. In 1992, the company issued its initial public offering of shares on Nasdaq (NASDAQ:ICUI). ICU Medical's main customers include: hospital emergency departments, wholesalers, mobile clinics, outpatient clinics, home health care and long-term care supply institutions, etc. Since its establishment, ICU company has maintained organic growth and extended its business to more than 90 countries and regions around the world through acquisitions. After more than 30 years of development, ICU Medical has now become one of the world's advanced infusion therapy companies (pure-play infusion therapy companies), with business covering more than 90 countries and regions around the world. The company's products include infusion solutions, smart infusion pumps, dedicated and non-special infusion kits and needle-free connectors, as well as pain management and safety software technologies designed to help achieve clinical, safety and workflow goals. In addition, ICU also manufactured the world's first needle-free automated infusion dispensing system with its advanced workflow technology, closed system transmission equipment (for equipped with hazardous infusion drugs) and cardiac monitoring system. The current business composition ratio of ICU is about: infusion consumables account for 40%; infusion systems account for 30%, infusion solutions account for 25%, and intensive care accounts for 5%. Among them, infusion consumables mainly include: gravity equipment, needleless intravenous injection connectors, as well as closed system transmission equipment and special infusion consumables. The infusion system includes: large-capacity and outpatient intravenous injection pumps, special infusion sets, electronic medical record interactive security software and on-site services. Infusion solutions include: disinfection solutions, infusion irrigation solutions and some nutritional solutions. Intensive care includes: hemodynamic monitoring systems for evaluating patient blood flow status, advanced sensors and catheters, and pressure sensors. ICU Medical's medical consumables always account for a high proportion of its product portfolio, ensuring that the company has always had good financial indicators. ICU Medical has direct branches in North America (USA, Canada), South America (Argentina, Chile, Peru, Colombia), Europe, the United Kingdom, South Africa, Australia and other regions, including China, India, Russia, Central Asia, Dealer channels are set up in Nordic countries and regions. In terms of production, ICU Medical has 4 factories, including 3 in the United States and 1 in Costa Rica. Among them, ICU Medical's investment in the Costa Ri processing plant reached US$13.2 million. In addition to producing more than 800 venous devices, the plant also produces award-winning Plum 360 and LifeCare PCA infusion pumps.
Smith Medical Devices (Beijing) Co., Ltd.
ICU Medical was founded in 1984 and is headquartered in San Clemente, California. In 1992, the company issued its initial public offering of shares on Nasdaq (NASDAQ:ICUI). ICU Medical's main customers include: hospital emergency departments, wholesalers, mobile clinics, outpatient clinics, home health care and long-term care supply institutions, etc. Since its establishment, ICU company has maintained organic growth and extended its business to more than 90 countries and regions around the world through acquisitions. After more than 30 years of development, ICU Medical has now become one of the world's advanced infusion therapy companies (pure-play infusion therapy companies), with business covering more than 90 countries and regions around the world. The company's products include infusion solutions, smart infusion pumps, dedicated and non-special infusion kits and needle-free connectors, as well as pain management and safety software technologies designed to help achieve clinical, safety and workflow goals. In addition, ICU also manufactured the world's first needle-free automated infusion dispensing system with its advanced workflow technology, closed system transmission equipment (for equipped with hazardous infusion drugs) and cardiac monitoring system. The current business composition ratio of ICU is about: infusion consumables account for 40%; infusion systems account for 30%, infusion solutions account for 25%, and intensive care accounts for 5%. Among them, infusion consumables mainly include: gravity equipment, needleless intravenous injection connectors, as well as closed system transmission equipment and special infusion consumables. The infusion system includes: large-capacity and outpatient intravenous injection pumps, special infusion sets, electronic medical record interactive security software and on-site services. Infusion solutions include: disinfection solutions, infusion irrigation solutions and some nutritional solutions. Intensive care includes: hemodynamic monitoring systems for evaluating patient blood flow status, advanced sensors and catheters, and pressure sensors. ICU Medical's medical consumables always account for a high proportion of its product portfolio, ensuring that the company has always had good financial indicators. ICU Medical has direct branches in North America (USA, Canada), South America (Argentina, Chile, Peru, Colombia), Europe, the United Kingdom, South Africa, Australia and other regions, including China, India, Russia, Central Asia, Dealer channels are set up in Nordic countries and regions. In terms of production, ICU Medical has 4 factories, including 3 in the United States and 1 in Costa Rica. Among them, ICU Medical's investment in the Costa Ri processing plant reached US$13.2 million. In addition to producing more than 800 venous devices, the plant also produces award-winning Plum 360 and LifeCare PCA infusion pumps.
Baxter (China) Investment Co., Ltd.
Baxter makes changes to the lives of millions of people around the world every day. The company's products and therapies are found in hospitals and clinics—from emergency rooms to operating rooms, from pharmacies to intensive care units—and improve patients' home treatment. For more than 80 years, I have always been at the important intersection of saving and continuing my life. Now, Baxter has the determination and ability to seize opportunities in the next few years to bring about change to global healthcare. Baxter came to China in the 1980s and is one of the largest multinational medical companies to enter the Chinese medical market earlier. Adhering to the corporate mission of "saving and continuing life", Baxter focuses on assisting in improving medical standards, expanding medical accessibility, and giving back to society, making meaningful contributions to the lives and quality of life of Chinese patients and helping China Sustainable development of medical care. Currently, Baxter has established 11 institutions and offices, 5 factories, 1 R&D center, and 1 technical service center in China.
Baxter (China) Investment Co., Ltd.
Baxter makes changes to the lives of millions of people around the world every day. The company's products and therapies are found in hospitals and clinics—from emergency rooms to operating rooms, from pharmacies to intensive care units—and improve patients' home treatment. For more than 80 years, I have always been at the important intersection of saving and continuing my life. Now, Baxter has the determination and ability to seize opportunities in the next few years to bring about change to global healthcare. Baxter came to China in the 1980s and is one of the largest multinational medical companies to enter the Chinese medical market earlier. Adhering to the corporate mission of "saving and continuing life", Baxter focuses on assisting in improving medical standards, expanding medical accessibility, and giving back to society, making meaningful contributions to the lives and quality of life of Chinese patients and helping China Sustainable development of medical care. Currently, Baxter has established 11 institutions and offices, 5 factories, 1 R&D center, and 1 technical service center in China.
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
Fresenius Kabi (China) Investment Co., Ltd.
Fresenius Cabi is a global enterprise focusing on the fields of infusion, blood transfusion and clinical nutrition. Fresenius Cabi provides reliable medical guarantees for patients with severe and chronic diseases with high-quality medicines, medical devices and services. Fresenius Cabi ’s product range includes intravenous medications, infusion therapy, clinical nutrition, and the medical devices required to apply these products. In the field of biosimilars, Fresenius Cabi focuses on autoimmune diseases and oncology. In terms of blood transfusion medicine and cell therapy devices, Fisseus Cabi provides blood component collection and in vitro cell therapy products. Taking care of life as its mission, Ferseniusca is committed to providing medical staff with essential medicines and technologies and helping them find quality solutions to solve problems. Since entering China, Fresenius Cabi has always regarded "caring for life" as the driving force for continuous development and progress, and is committed to helping the Chinese people improve their health and quality of life. Rooted in China for more than 30 years, Fresenius Cabi has been engaged in medicines, clinical nutrition, medical devices and other fields, thanks to its excellent products and technologies, standardized management, professional services, and efficient operation of R&D, production and marketing systems.业务领域取得骄人业绩，并发展成为中国临床营养、肾病营养治疗和麻醉治疗领域的领导者之一。
Fresenius Kabi (China) Investment Co., Ltd.
Fresenius Cabi is a global enterprise focusing on the fields of infusion, blood transfusion and clinical nutrition. Fresenius Cabi provides reliable medical guarantees for patients with severe and chronic diseases with high-quality medicines, medical devices and services. Fresenius Cabi ’s product range includes intravenous medications, infusion therapy, clinical nutrition, and the medical devices required to apply these products. In the field of biosimilars, Fresenius Cabi focuses on autoimmune diseases and oncology. In terms of blood transfusion medicine and cell therapy devices, Fisseus Cabi provides blood component collection and in vitro cell therapy products. Taking care of life as its mission, Ferseniusca is committed to providing medical staff with essential medicines and technologies and helping them find quality solutions to solve problems. Since entering China, Fresenius Cabi has always regarded "caring for life" as the driving force for continuous development and progress, and is committed to helping the Chinese people improve their health and quality of life. Rooted in China for more than 30 years, Fresenius Cabi has been engaged in medicines, clinical nutrition, medical devices and other fields, thanks to its excellent products and technologies, standardized management, professional services, and efficient operation of R&D, production and marketing systems.业务领域取得骄人业绩，并发展成为中国临床营养、肾病营养治疗和麻醉治疗领域的领导者之一。
Abbott Trading (Shanghai) Co., Ltd.
In 1888, Abbott Pharmaceutical Factory was founded in Chicago, USA by its founder, Dr. Wallace C. Abbott, to help people in more than 160 countries and regions around the world live a wonderful life. Abbott has been operating in China as early as the 1930s and has been operating since 1988. Abbott is rooted in China and continues to expand its market. In the past 30 years, it has provided Chinese consumers with a variety of nutritional products, medicines and medical products. At present, in addition to establishing a Chinese headquarters in Shanghai, Abbott has also established 16 offices, 4 factories and 2 R&D centers, with more than 6,000 employees. Abbott develops, produces and distributes products covering nutritional products, medicines, medical devices and diagnostic products. Products and services meet the needs of many aspects from disease prevention to diagnosis, treatment to recovery, and are based on local needs to achieve common health goals. Since 2010, Abbott has continued to invest in the Chinese market, developing, producing and distributing products in China, covering nutritional products, medicines, medical devices and diagnostic products, products and services that can meet the needs of disease prevention to diagnosis and treatment to recovery. . In 2014, the advanced nutritional products factory established in Jiaxing with an investment of US$230 million was officially opened. This is a major investment project in China, showing Abbott's strong attempt to improve the health of all Chinese people. Abbott attaches importance to China's local R&D capabilities, not only establishes R&D centers in Shanghai, but also establishes Shanghai Children's Medical Center with partners. Through local clinical trials and operations, Abbott China's R&D capabilities have been greatly improved. In terms of medical innovation, Abbott China has worked together with other R&D centers around the world to jointly respond to global medical problems. Abbott believes in the potential of life and continues to launch high-quality products and services, ranging from newborns to adults, from nutrition and diagnostics to health care and medical treatment. Abbott's passion and care make science an inexhaustible spring for a healthy life, committed to stimulating everyone's potential and pursuing a healthier and better life.
Abbott Trading (Shanghai) Co., Ltd.
In 1888, Abbott Pharmaceutical Factory was founded in Chicago, USA by its founder, Dr. Wallace C. Abbott, to help people in more than 160 countries and regions around the world live a wonderful life. Abbott has been operating in China as early as the 1930s and has been operating since 1988. Abbott is rooted in China and continues to expand its market. In the past 30 years, it has provided Chinese consumers with a variety of nutritional products, medicines and medical products. At present, in addition to establishing a Chinese headquarters in Shanghai, Abbott has also established 16 offices, 4 factories and 2 R&D centers, with more than 6,000 employees. Abbott develops, produces and distributes products covering nutritional products, medicines, medical devices and diagnostic products. Products and services meet the needs of many aspects from disease prevention to diagnosis, treatment to recovery, and are based on local needs to achieve common health goals. Since 2010, Abbott has continued to invest in the Chinese market, developing, producing and distributing products in China, covering nutritional products, medicines, medical devices and diagnostic products, products and services that can meet the needs of disease prevention to diagnosis and treatment to recovery. . In 2014, the advanced nutritional products factory established in Jiaxing with an investment of US$230 million was officially opened. This is a major investment project in China, showing Abbott's strong attempt to improve the health of all Chinese people. Abbott attaches importance to China's local R&D capabilities, not only establishes R&D centers in Shanghai, but also establishes Shanghai Children's Medical Center with partners. Through local clinical trials and operations, Abbott China's R&D capabilities have been greatly improved. In terms of medical innovation, Abbott China has worked together with other R&D centers around the world to jointly respond to global medical problems. Abbott believes in the potential of life and continues to launch high-quality products and services, ranging from newborns to adults, from nutrition and diagnostics to health care and medical treatment. Abbott's passion and care make science an inexhaustible spring for a healthy life, committed to stimulating everyone's potential and pursuing a healthier and better life.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
